pharmaphorum

JULY 13, 2022

And while pharma companies are working hard to find treatments for these diseases, they have a major problem that must be addressed before that work can be done effectively: the lack of objective, quantitative measurement tools for assessing the progression – or even the presence or absence – of these conditions.

Trials 98

Trials Clinical Trials Clinical Trials Pharma Companies 98

XTalks

FEBRUARY 21, 2024

The importance of identifying effective solutions for MASH is evident from the overall interest from the pharmaceutical industry and the competition in developing treatments for this serious liver condition. There are on-going studies to develop formulations with extended duration of action.

Clinical Trials 59

Clinical Trials Clinical Trials Trials Insulin 59

XTalks

FEBRUARY 14, 2024

Allocation of Profits, PBMs Under Fire The CEOs defended high prescription drug prices saying that a big chunk of pharma profits go towards funding the research and development of new medicines. Murphy interrogated this claim and specifically questioned the way companies allocate revenue.

Drugs 52

Drugs Insulin Pharmacy Development 52

XTalks

JUNE 14, 2024

The investment was announced by Vic Fedeli, Minister of Economic Development, Job Creation and Trade, at the Biotechnology Innovation Organization (BIO) International Convention, the world’s largest life sciences conference, in San Diego last week. It also delivers $12 billion in exports to global markets.

Life Science 52

Life Science Insulin Research Manufacturing 52

XTalks

JANUARY 5, 2024

Related: Zepbound, Obesity Version of Eli Lilly’s Mounjaro, Finally Gets FDA Nod So far, LillyDirect provides support for 14 Lilly medicines, with 12 being different formulations and types of insulin. In addition to these and Zepbound, Lilly’s medication for migraine management, Emgality (galcanezumab), is also available through the website.

Drugs 59

Drugs Pharmacy Cosmetics Medicine 59

pharmaphorum

JUNE 2, 2022

In 1983, the US Congress passed the Orphan Drug Act to encourage more pharmaceutical companies to engage in R&D to develop treatments for rare diseases through the offering of financial incentives. As covered in a previous article , the importance of R&D to develop treatments for rare diseases is high. Raising questions.

Drugs 52

Drugs Sales Marketing Development 52

pharmaphorum

APRIL 13, 2022

The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. Ben Hargreaves looks at why insulin’s price is so controversial and whether this could be set to change. Insulin rationing. In the US, approximately 37.3

Insulin 130

Insulin Drugs Production Hormones 130

Delveinsight

JULY 21, 2021

However, some of the key pharma companies at the global level have shifted their focus towards these diverse diseases. Through this article, we have covered the major autoimmune diseases and the key companies striving to transform the treatment landscape of the respective disease. It is also known as insulin-dependent diabetes.

Pharma Companies 94

Pharma Companies Marketing Development Insulin 94

Pharma Marketing Network

OCTOBER 27, 2020

Don ( PMN): This is really interesting too and that is the one that we’ve spoken about earlier in previous conversations was the aerosolized insulin? Robin (Guest): Eliminating the needle and it’s a smart connected device and so you can track the insulin uses really really easily. Robin (Guest): Yup. Don ( PMN): Wow.

Insulin 52

Insulin Marketing Doctor Doctors 52

Pharma Marketing Network

OCTOBER 27, 2020

Don ( PMN): This is really interesting too and that is the one that we’ve spoken about earlier in previous conversations was the aerosolized insulin? Robin (Guest): Eliminating the needle and it’s a smart connected device and so you can track the insulin uses really really easily. Robin (Guest): Yup. Don ( PMN): Wow.

Insulin 52

Insulin Doctor Doctors Marketing 52

pharmaphorum

MAY 17, 2021

UK biotech Arecor Therapeutics has announced plans to float on the London stock market, to fund plans to develop novel formulations of insulins and other biological drugs with enhanced properties. The initial therapeutic focus is diabetes, with three insulin-based products in development.

Insulin 52

Insulin Production Marketing Pharma Companies 52

World of DTC Marketing

JUNE 16, 2021

The pharma industry has been riding a wave of public approval since they developed a vaccine to fight COVID-19, but that goodwill is going to be short lived thanks, in part, to the $56,000 price tag of Biogen’s new drug and insulin that too many people still can’t afford.

Drugs 180

Drugs Branding Medicine Insulin 180

STAT News

MARCH 10, 2023

Enjoy, and see you soon … By law, Medicare will have to take a medication’s efficacy and its research and development costs into account when it starts to negotiate drug prices — but recent research shows pharma companies ignore those factors when they pick prices for their products , STAT explains. Two

Insulin 96

Insulin Pharmacy Pharma Companies Drugs 96

Pharmaceutical Technology

MAY 17, 2023

However, Randy Burkholder, vice president of policy and research for the industry group Pharmaceutical Research and Manufacturers of America (PhRMA), said this provision amounted to government “price setting” that would harm future research and development efforts.

Insulin 130

Insulin Drugs Pharma Companies Manufacturing 130

XTalks

MAY 13, 2021

Novo Nordisk’s oral GLP-1 diabetes drug Rybelsus (semaglutide) has been up in the ranks this year in pharma TV ad spending, with the Danish pharma company having spent $19.9 The drug is a human glucagon-like peptide-1 (GLP-1) agonist that functions to increase insulin secretion from the pancreas. million and $18.6

Insulin 104

Insulin Marketing Drugs Branding 104

Delveinsight

AUGUST 25, 2021

Pharmaceutical companies play a vital part in our lives and in helping us to live healthier lives. The pharmaceutical industry finds, develops, manufactures, and promotes medicines or pharmaceutical drugs for usage as medications that are administered (or self-administered) to patients in order to cure, vaccinate, or relieve symptoms.

Vaccine 98

Vaccine Vaccination Drugs Sales 98

XTalks

AUGUST 17, 2020

Immunotherapy continues to be a burgeoning field, with immune-based therapies being among the leading treatments being developed in oncology and autoimmunity. A growing area in the immunotherapy space is the development of biological modulators, which are genetically engineered proteins that target specific components of the immune system.

Protein 98

Protein Engineer Immune Response In-Vivo 98

pharmaphorum

JUNE 10, 2021

Nowhere has this need for healthy companies been more apparent than during the current global coronavirus pandemic, with multiple manufacturers making COVID-19 vaccines rapidly available to the public. What’s Next: How Should Pharma Companies Respond?

Manufacturing 105

Manufacturing Drugs Pharma Companies Pharmacy 105

pharmaphorum

NOVEMBER 4, 2021

Other elements of the plans include tax penalties if pharma companies hike their prices faster than inflation, setting a cap of $35 per month out-of-pocket for insulin, and making sure that Medicare Part D patients don’t pay more than $2,000 per year for medications bought at the pharmacy.

Drugs 52

Drugs Insulin Medicine Marketing 52

pharmaphorum

SEPTEMBER 1, 2020

Whilst the scientific revolution of the 17th century had spread ideas of rationalism and experimentation, and the industrial revolution had transformed the production of goods in the late 18th century, the marrying of the two concepts for the benefit of human health was a comparatively late development.

Medicine 145

Medicine Insulin Drugs Pharmacy 145

XTalks

JANUARY 23, 2025

Novo Nordisk and Sanofi were also recognized in Time’s 2024 list of the World’s Most Sustainable Companies. Lets explore why these companies earned their spots and how they are driving sustainable healthcare innovation.

Insulin 104

Insulin Production Genomics Genome 104

World of DTC Marketing

DECEMBER 7, 2021

LEAD IN: Pharma companies are a business and have the right to make money but at what cost and how much is enough? There is no debate that today’s pharmaceutical companies have helped us lead longer and better lives, but they have made their shareholders and CEOs a lot of money in the process. Is this acceptable?

Vaccine 222

Vaccine Vaccination Insulin Pharma Companies 222

XTalks

DECEMBER 3, 2024

The diabetes medication landscape continues to evolve, driven by advancements in drug development, increasing prevalence of the condition and a growing demand for innovative therapies. The company has also been dealing with imitations of its semaglutide-based products, including the obesity treatment Wegovy.

Sales 105

Sales Insulin FDA Approval Drugs 105